Novoxel GmbH manufactures and distributes medical-technical and cosmetic-technical devices, including accessories, and provides related services. Novoxel GmbH is a family business.
Die Herstellung und der Vertrieb von medizinisch-technischen und kosmetik-technischen Geräten inkl. Zubehör sowie die Einbringung von Serviceleistungen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 187499 (as of 1 November 2026)
| Name | Type | City |
|---|---|---|
| Eithan Shavit | Geschäftsführer(in) | San Mateo, Kalifornien, USA |
| Jonathan Shavit | Geschäftsführer(in) | Herzilia, Israel |
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 187499 (as of 1 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2022 | €863,102 | €30,056 | €231,959 | 2 |
| 2021 | €823,638 | €25,215 | €192,325 | — |
| 2020 | small company1 | €119,374 | €153,370 | 1 |
| 2019 | small company1 | -€36,445 | €261,925 | — |
| 2018 | small company1 | -€86,669 | €167,556 | 2 |
| 2017 | small company1 | €73,014 | €168,933 | 2 |
| 2016 | small company1 | -€43,827 | €126,456 | 1 |
| 2015 | — | -€36,093 | €53,635 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
Sign in to download data
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 187499 (as of 1 November 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €123,660 | 18.4% |
| Material Costs | €540,823 | 80.3% |
| Depreciation | €7,717 | 1.1% |
| Interest & Similar | €1,052 | 0.2% |